GCM Medical Group

What GCM Medical Group does

GCM Medical Group, PSC is a privately-held clinical research site organization (SRO) founded in 2010 and headquartered at 62 Calle José Martí in the Floral Park / Hato Rey district of San Juan, Puerto Rico. The company conducts Phase II–IV clinical trials on behalf of pharmaceutical and biotechnology sponsors across four therapeutic verticals: rheumatology (Rheumatoid Arthritis, Sjögren's, Psoriatic Arthritis), dermatology (Atopic Dermatitis, Psoriasis adult and pediatric, Mycosis Fungoides / Cutaneous T-Cell Lymphoma), endocrinology / metabolism (Type 2 Diabetes Mellitus), and oncology. GCM generates revenue through professional services contracts with pharma and biotech sponsors for protocol execution, patient recruitment, and study coordination; patient participation is free of cost and voluntary. The company differentiates via a bilingual (English/Spanish) operation and an island-wide patient transportation service that extends the effective catchment of its single physical site to all of Puerto Rico, a meaningful access advantage in a market where geography and language typically depress enrollment.

The underlying technology stack is modest: a WordPress-based bilingual marketing website, Google Forms for condition-specific patient pre-screening and registration, and standard clinical operations infrastructure. GCM's competitive position rests on a multidisciplinary investigator team (specialists in rheumatology, dermatology, endocrinology, pediatric rheumatology, and oncology with credentials from institutions including Baylor College of Medicine and the UPR Medical Sciences Campus), a Director of Clinical Development with 20+ years of pharmaceutical industry experience, and institutional knowledge from 10+ years of operating in Puerto Rico's clinical research ecosystem. The company self-positions as 'Leaders in Clinical Trials in Puerto Rico' and '10 Years of Medical Excellence.'

The business is founder/physician-led by Dr. Gregorio Cortes Maisonet (President and Medical Director), with no disclosed external investment, parent company, or institutional funding rounds. The company operates from a single site with approximately 20+ personnel (11–50 range), no mobile applications, no APIs, no disclosed partnerships or alliances, and no AI/ML capabilities. Revenue is not publicly disclosed and there are no third-party press references in the available input, indicating limited external visibility. The combination of multi-vertical trial activity, a stable 15-year operating history, and the absence of any signaled scaling move (new site, acquisition, funding) suggests a steady-state, profitable-but-not-scaling clinical research site rather than a venture-stage growth asset.

Name

GCM Medical Group

Legal name

GCM Medical Group, PSC

Website

https://gcmmedical.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

GCM Medical Group is a privately-held Puerto Rico-based clinical research site founded in 2010 that conducts Phase II–IV clinical trials in rheumatology, dermatology, endocrinology, and oncology on behalf of pharmaceutical and biotech sponsors, recruiting patients through its bilingual San Juan headquarters and island-wide transportation services.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Investigator & Site Training / GCP Support (HLAGACAF)

Keywords

• Clinical research services
• Clinical trial management
• Pharmaceutical research
• Patient recruitment
• Therapeutic research

Headquarters

HQ city

San Juan

HQ country

Puerto Rico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Clinical Research Services: GCM Medical Group conducts clinical trials on behalf of pharmaceutical and biotech sponsors. The organization recruits and enrolls patients with specific conditions (Rheumatoid Arthritis, Sjögren's, Psoriatic Arthritis, Atopic Dermatitis, Psoriasis, Mycosis Fungoides, Type 2 Diabetes Mellitus) and administers investigational treatments per study protocols. Revenue is derived from contracts with pharmaceutical sponsors for the execution of clinical research studies.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

GCM Medical Group, PSC operates a clinical research center in Puerto Rico conducting Phase II–IV clinical trials for pharmaceutical and biotech sponsors. Its trial portfolio spans rheumatology, dermatology, endocrinology, and oncology, supported by a multidisciplinary physician team, dedicated study coordinators, and an island-wide patient transportation program that enables free patient participation.

Product overview

GCM Medical Group is a clinical research center network offering specialized clinical trial services across three therapeutic areas: Rheumatology, Dermatology, and Endocrinology. Founded in 2010 in San Juan, Puerto Rico, the organization operates as a unified clinical research platform with integrated transportation services throughout the island. The core product consists of conducting clinical studies for conditions including Rheumatoid Arthritis, Psoriasis, Atopic Dermatitis, and Type 2 Diabetes Mellitus. Patient registration is facilitated through online forms linked to specific study conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase II-IV Clinical Trial Services

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• ICON plc: Major global CRO formed via the PRA Health Sciences merger, offering full-service clinical development and site services. Comparable to GCM as a sponsor-facing clinical research services provider, with much broader therapeutic and geographic coverage.
• Medpace: Mid-to-large global CRO focused on Phase II–IV clinical trial execution across multiple therapeutic areas. Comparable to GCM in therapeutic breadth and sponsor-paid service model, though at substantially larger scale.
• Syneos Health: Large global biopharmaceutical solutions organization offering CRO services plus a dedicated site solutions division. Comparable to GCM as a sponsor-paid clinical trial services provider, but operates at vastly greater scale and across all geographies.
• IQVIA: World's largest CRO with broad therapeutic-area coverage, technology platforms, and dedicated clinical site networks. Comparable to GCM in the underlying activity of executing clinical trials for sponsors, but at enterprise scale across dozens of countries.
• PPD (Pharmaceutical Product Development, part of Thermo Fisher Scientific): Large global CRO offering comprehensive clinical development services including site management and patient recruitment. Comparable to GCM in the activity of executing trials for pharma sponsors, but at multinational scale with extensive site networks.

Direct peers

• Javara: Clinical research site network integrated with U.S. health systems, conducting trials across multiple therapeutic areas for pharma/biotech sponsors. Directly comparable to GCM as a site operator with patient recruitment and study execution as the core service offering.
• PMG Research: Independent clinical research site network operating multiple U.S. locations across diverse therapeutic areas. Comparable to GCM in that it executes Phase II–IV trials at the site level for pharma sponsors with investigator-led recruitment.
• QPS Holdings: Global CRO providing early-stage and specialty clinical research services, including site-based Phase II–IV trial execution. Comparable to GCM in therapeutic specialization and sponsor-paid service model.
• Worldwide Clinical Trials: Mid-size global CRO with therapeutic-area specialization in neuroscience, cardiometabolic, and rare diseases. Comparable to GCM as a contract research services provider to pharma sponsors, though at much larger scale and broader geographic reach.
• Velocity Clinical Research: Integrated site network operating multiple clinical research sites across the U.S. Comparable as a multi-therapeutic clinical trial site organization that recruits patients and executes Phase II–IV studies for pharma sponsors — same business model as GCM but at greater geographic scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/gcm_medical
• Facebookfacebook.com/gcmmedical
• LinkedInlinkedin.com/company/gcm-medical-group-psc

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GCM Medical Group